Immunohematology Market Growing at a CAGR Of 3.5% and to Target US$ 1,991.8 Million By 2025 | Transparency Market Research

Global 𝐢𝐦𝐦𝐮𝐧𝐨𝐡𝐞𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲 market was valued at US$ 1,462.1 Mn in 2016 and is projected to expand at a CAGR of 3.5% from 2017 to 2025 to reach value of US$ 1,991.8 Mn by 2025. This report offers a thorough understanding of the immunohematology market across the globe, its key trends, drivers, restraints, and opportunities.

Rising awareness among people in developed as well as developing countries is expected to drive the global immunohematology market in the near future. Increasing health care expenditure and rising worldwide concerns about medical safety are also driving the global immunohematology market. The Asia Pacific region has witnessed gradual adoption of new immunohematology technologies, increasing health care expenditure, and changing dynamics of the in vitro diagnostics industry in the region. The market in APAC is anticipated to expand at a CAGR of 4.4% from 2017 to 2025. The global immunohematology market has been witnessing a significant shift from manual systems toward automated systems. The rate of adoption of automated systems by laboratories is increasing. This has augmented the demand for automated analyzers. In addition, the increasing focus on efficiency and data precision promotes growth of the market. The adoption of automated systems has boosted the throughput and reduced the burden of routine tasks. A substantial number of clinical trial studies are in process to innovate new technologies and procedures for blood typing. Research and development programs for the advancement of new products in immunohematology are expected to provide significant opportunities to the immunohematology market in the next few years.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐌𝐚𝐢𝐥 𝐈𝐝 𝐟𝐨𝐫 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31544

𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐭𝐨 𝐝𝐫𝐢𝐯𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭

The modern methods of blood banking offer rapid results and better accuracy. These methods enable establishing of strong monitoring plans and quick tracing of compatible blood donors. Advancements in the immunohematology technology have led to rapid development in the diagnostic approach toward in vitro study of the antigen-antibody interaction, facilitating improvement in the compatibility reaction between the donor's blood and the recipient's blood. Technological improvements in devices and reagents available for immunohematology testing have enabled clinicians to provide proper emergency assistance to patients. These technological advancements include development of automated systems which make the identification process easier and provide more accurate results as compared to manual systems. Sophisticated antiglobulin screening instruments and assays are well-recognized and validated for proper blood typing. However, high costs associated with these systems and assays present a significant challenge for the market. Moreover, cost of setting of a sophisticated, dedicated laboratory with advanced tools can be substantially high, which makes the market entry of new and small players difficult. This factor is projected to hamper the global immunohematology market during the forecast period. Moreover, people in developing economies such as India and China are opting for private insurance for their medical needs. Increasing disposable income, rising health care awareness, and developing health care infrastructure have led to steady rise in the demand for better diagnosis and treatment measures in these countries.

𝐑𝐞𝐚𝐠𝐞𝐧𝐭𝐬 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐬 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐟𝐨𝐥𝐥𝐨𝐰𝐞𝐝 𝐛𝐲 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐀𝐧𝐚𝐥𝐲𝐳𝐞𝐫𝐬 𝐒𝐞𝐠𝐦𝐞𝐧𝐭

The global immunohematology market has been segmented in terms of product, application, end-user, and geography. Based on product, the global immunohematology market has been segmented into analyzers and reagents. The analyzers segment has been sub-segmented into automatic and semi-automatic/non-automatic immunohematology analyzers. The reagents segment is expected to dominate the immunohematology market during the forecast period. This is attributable to the rising number of customized reagents used in blood typing and antibody screening processes. Moreover, increasing demand for blood and blood products significantly boosts the demand for reagents and assay kits. Growing trend of consolidation among diagnostic laboratories and rising demand for preventive care and diagnosis are leading to high-volume processing, which augments the demand for high-throughput automatic analyzer systems.

𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐲 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐭𝐨 𝐛𝐞 𝐭𝐡𝐞 𝐌𝐨𝐬𝐭 𝐏𝐫𝐨𝐦𝐢𝐬𝐢𝐧𝐠 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐟𝐨𝐫 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭

Based on application, the global immunohematology market has been segmented into blood typing and antibody screening. Antibody screening test is a clinical procedure usually performed in a blood bank, hospital laboratory, or clinical laboratory before blood transfusion in order to detect the presence of unexpected antibodies, which can lead to an undesirable response during the transfusion procedure. Based on end-user, the market has been segmented into hospitals, academic & research institutes, diagnostic & reference laboratories, and blood banks. The hospitals segment is expected to remain dominant during the forecast period.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 | 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 - https://www.transparencymarketresearch.com/checkout.php?rep_id=31544<ype=S

𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜 𝐭𝐨 𝐨𝐟𝐟𝐞𝐫 𝐋𝐮𝐜𝐫𝐚𝐭𝐢𝐯𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐭𝐨 𝐈𝐦𝐦𝐮𝐧𝐨𝐡𝐞𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭

Geographically, the global immunohematology market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to be the largest market for immunohematology during the forecast period. High adoption of advanced technologies and a wide base of diagnostic laboratories and blood banks are factors responsible for the major share held by North America in the global immunohematology market. The Asia Pacific region has witnessed gradual adoption of new immunohematology technologies, increasing health care expenditure, and changing dynamics of the in vitro diagnostics industry. These factors are leading to adoption of new technologies by hospitals and diagnostic laboratories in the region. Increase in the disposable income of people in emerging markets in Asia Pacific such as India and China is leading to rise in the health care spending. Moreover, adoption of advanced treatment options is increasing in developing regions, which provides growth opportunities to the global immunohematology market. One of the most significant factors driving the immunohematology market in developing countries such as India and China is the availability of superior treatment facilities at lower prices compared to western countries. This attracts patients from high-prevalence regions such as the U.S. and Europe to these countries. Growing medical tourism industry in developing economies is anticipated to provide growth opportunities to the market for immunohematology in the next few years.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐬𝐮𝐜𝐡 𝐚𝐬 𝐁𝐢𝐨-𝐑𝐚𝐝 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬, 𝐈𝐧𝐜., 𝐆𝐫𝐢𝐟𝐨𝐥𝐬 𝐒.𝐀., 𝐚𝐧𝐝 𝐎𝐫𝐭𝐡𝐨 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐚𝐫𝐞 𝐥𝐢𝐤𝐞𝐥𝐲 𝐭𝐨 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞 𝐭𝐨 𝐥𝐞𝐚𝐝 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐦𝐦𝐮𝐧𝐨𝐡𝐞𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭

Major companies operating in the immunohematology market and profiled in the report are Bio-Rad Laboratories, Inc., Grifols S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, and Siemens Healthineers. Bio-Rad Laboratories dominates the market, due to strong penetration of its flagship products in the global immunohematology market.

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 -

𝐔𝐫𝐢𝐧𝐚𝐫𝐲 𝐂𝐚𝐭𝐡𝐞𝐭𝐞𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.einpresswire.com/article/576040433/urinary-catheters-market-size-is-expected-to-reach-us-5-1-billion-and-growing-at-4-5-cagr-by-2028

𝐃𝐍𝐀 𝐓𝐞𝐬𝐭 𝐊𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.globenewswire.com/news-release/2022/04/13/2421920/0/en/DNA-Test-Kits-Market-to-Cross-US-2-7-Bn-Mark-by-2030-TMR-Report.html

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.